Global Diabetic Retinopathy Market Analysis By Type (Non-Proliferative Diabetic Retinopathy (NPDR), Proliferative Diabetic Retinopathy (PDR)), By Treatment (Anti-VEGF Injections, Corticosteroids, Laser Treatment, Surgery), By End User (Hospitals & Clinics, Ophthalmology Centers, Others) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Published date: April 2025
Report ID: 145648
Number of Pages: 397
Format:

- 1. Executive Summary
  - 1.1. Definition
  - 1.2. Market Snapshot
  - 1.3. Market Overview
  - 1.4. Segment Overview
  - 1.5. Regional Overview
  - 1.6. Competitive Landscape
  - 1.7. Taxonomy
- 2. Global Market Overview
  - 2.1. Global Market Insights and Industry Overview
  - 2.2. Market Dynamics
    
    2.2.1. Drivers
    
    2.2.2. Restraints
    
    2.2.3. Opportunities
    
    2.2.4. Key Diabetic Retinopathy Market Trends
  - 2.3. Regulatory Framework
  - 2.4. Opportunity Map Analysis
  - 2.5. Opportunity Orbits
  - 2.6. PESTLE Analysis
  - 2.7. PORTER’S Five Force Analysis
  - 2.8. Drivers & Restraints Impact Analysis
  - 2.9. Value Chain Analysis
    
    2.9.1. List of Raw Materials Suppliers
    
    2.9.2. List of Diabetic Retinopathy Manufacturers
    
    2.9.3. List of Dealer/Distributors
  - 2.10. Regional Market Share and BPS Analysis
  - 2.11. Impact of Macro-economic Factors/Geopolitical Factors
- 3. Global Diabetic Retinopathy Market Analysis and Forecast, By Segment, 2020-2034
  - 3.1. Key Findings
  - 3.2. Global Diabetic Retinopathy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  - 3.3. Global Diabetic Retinopathy Market Attractiveness Analysis, By Product Type
    
    3.3.1. Non-Proliferative Diabetic Retinopathy (NPDR)
    
    3.3.1.1. Insights
    
    3.3.1.2. Key Takeaways
    
    3.3.2. Proliferative Diabetic Retinopathy (PDR)
    
    3.3.2.1. Insights
    
    3.3.2.2. Key Takeaways
  - 3.4. Global Diabetic Retinopathy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  - 3.5. Global Diabetic Retinopathy Market Attractiveness Analysis, By Application
    
    3.5.1. Anti-VEGF Injections
    
    3.5.1.1. Insights
    
    3.5.1.2. Key Takeaways
    
    3.5.2. Corticosteroids
    
    3.5.2.1. Insights
    
    3.5.2.2. Key Takeaways
    
    3.5.3. Laser Treatment
    
    3.5.3.1. Insights
    
    3.5.3.2. Key Takeaways
    
    3.5.4. Surgery
    
    3.5.4.1. Insights
    
    3.5.4.2. Key Takeaways
  - 3.6. Global Diabetic Retinopathy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
  - 3.7. Global Diabetic Retinopathy Market Attractiveness Analysis, By Distribution Channel
    
    3.7.1. Hospitals & Clinics
    
    3.7.1.1. Insights
    
    3.7.1.2. Key Takeaways
    
    3.7.2. Ophthalmology Centers
    
    3.7.2.1. Insights
    
    3.7.2.2. Key Takeaways
    
    3.7.3. Others
    
    3.7.3.1. Insights
    
    3.7.3.2. Key Takeaways
- 4. Global Diabetic Retinopathy Market Analysis and Forecast, By Region, 2020-2034
  - 4.1. Key Findings
  - 4.2. Global Diabetic Retinopathy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2020-2034
    
    4.2.1. North America
    
    4.2.1.1. Regional Insights
    
    4.2.2. Europe
    
    4.2.2.1. Regional Insights
    
    4.2.3. Asia Pacific
    
    4.2.3.1. Regional Insights
    
    4.2.4. Latin America
    
    4.2.4.1. Regional Insights
    
    4.2.5. Middle East & Africa
    
    4.2.5.1. Regional Insights
  - 4.3. Global Diabetic Retinopathy Market Attractiveness Analysis, By Region
- 5. North America Diabetic Retinopathy Market Analysis and Forecast, 2020-2034
  - 5.1. Key Findings
  - 5.2. North America Diabetic Retinopathy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  - 5.3. North America Diabetic Retinopathy Market Attractiveness Analysis, By Product Type
  - 5.4. North America Diabetic Retinopathy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  - 5.5. North America Diabetic Retinopathy Market Attractiveness Analysis, By Application
  - 5.6. North America Diabetic Retinopathy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
  - 5.7. North America Diabetic Retinopathy Market Attractiveness Analysis, By Distribution Channel
  - 5.8. North America Diabetic Retinopathy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 5.9. North America Diabetic Retinopathy Market Attractiveness Analysis, By Country
    
    5.9.1. The US
    
    5.9.2. Canada
- 6. Europe Diabetic Retinopathy Market Analysis and Forecast, 2020-2034
  - 6.1. Key Findings
  - 6.2. Europe Diabetic Retinopathy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  - 6.3. Europe Diabetic Retinopathy Market Attractiveness Analysis, By Product Type
  - 6.4. Europe Diabetic Retinopathy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  - 6.5. Europe Diabetic Retinopathy Market Attractiveness Analysis, By Application
  - 6.6. Europe Diabetic Retinopathy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
  - 6.7. Europe Diabetic Retinopathy Market Attractiveness Analysis, By Distribution Channel
  - 6.8. Europe Diabetic Retinopathy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 6.9. Europe Diabetic Retinopathy Market Attractiveness Analysis, By Country
    
    6.9.1. Germany
    
    6.9.2. The UK
    
    6.9.3. France
    
    6.9.4. Spain
    
    6.9.5. Italy
    
    6.9.6. Russia
    
    6.9.7. Netherland
    
    6.9.8. Rest of Europe
- 7. Asia Pacific Diabetic Retinopathy Market Analysis and Forecast, 2020-2034
  - 7.1. Key Findings
  - 7.2. Asia Pacific Diabetic Retinopathy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  - 7.3. Asia Pacific Diabetic Retinopathy Market Attractiveness Analysis, By Product Type
  - 7.4. Asia Pacific Diabetic Retinopathy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  - 7.5. Asia Pacific Diabetic Retinopathy Market Attractiveness Analysis, By Application
  - 7.6. Asia Pacific Diabetic Retinopathy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
  - 7.7. Asia Pacific Diabetic Retinopathy Market Attractiveness Analysis, By Distribution Channel
  - 7.8. Asia Pacific Diabetic Retinopathy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 7.9. Asia Pacific Diabetic Retinopathy Market Attractiveness Analysis, By Country
    
    7.9.1. China
    
    7.9.2. Japan
    
    7.9.3. South Korea
    
    7.9.4. India
    
    7.9.5. Australia
    
    7.9.6. New Zealand
    
    7.9.7. Singapore
    
    7.9.8. Thailand
    
    7.9.9. Vietnam
    
    7.9.10. Rest of Asia Pacific
- 8. Latin America Diabetic Retinopathy Market Analysis and Forecast, 2020-2034
  - 8.1. Key Findings
  - 8.2. Latin America Diabetic Retinopathy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  - 8.3. Latin America Diabetic Retinopathy Market Attractiveness Analysis, By Product Type
  - 8.4. Latin America Diabetic Retinopathy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  - 8.5. Latin America Diabetic Retinopathy Market Attractiveness Analysis, By Application
  - 8.6. Latin America Diabetic Retinopathy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
  - 8.7. Latin America Diabetic Retinopathy Market Attractiveness Analysis, By Distribution Channel
  - 8.8. Latin America Diabetic Retinopathy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 8.9. Latin America Diabetic Retinopathy Market Attractiveness Analysis, By Country
    
    8.9.1. Brazil
    
    8.9.2. Mexico
    
    8.9.3. Rest of Latin America
- 9. Middle East & Africa Diabetic Retinopathy Market Analysis and Forecast, 2020-2034
  - 9.1. Key Findings
  - 9.2. Middle East & Africa Diabetic Retinopathy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  - 9.3. Middle East & Africa Diabetic Retinopathy Market Attractiveness Analysis, By Product Type
  - 9.4. Middle East & Africa Diabetic Retinopathy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  - 9.5. Middle East & Africa Diabetic Retinopathy Market Attractiveness Analysis, By Application
  - 9.6. Middle East & Africa Diabetic Retinopathy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
  - 9.7. Middle East & Africa Diabetic Retinopathy Market Attractiveness Analysis, By Distribution Channel
  - 9.8. Middle East & Africa Diabetic Retinopathy Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 9.9. Middle East & Africa Diabetic Retinopathy Market Attractiveness Analysis, By Country
    
    9.9.1. South Africa
    
    9.9.2. Saudi Arabia
    
    9.9.3. UAE
    
    9.9.4. Rest of Middle East & Africa
- 10. Competitive Landscape & Company Profiles
  - 10.1. Market Competition Scenario Analysis, By Company
    
    10.1.1. Key Takeaways
  - 10.2. Overview of Major Market Players
  - 10.3. Competitor Landscape
  - 10.4. Strategic Mapping
  - 10.5. Company Life Cycle Analysis
  - 10.6. Company Market Share Analysis
  - 10.7. Company Profiles
    
    10.7.1. Novartis AG
    
    10.7.1.1. Company Details
    
    10.7.1.2. Business Overview
    
    10.7.1.3. Product Portfolio
    
    10.7.1.4. Financial Insights
    
    10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.1.6. SWOT Analysis
    
    10.7.1.7. Geographic Footprint
    
    10.7.2. Bayer AG
    
    10.7.2.1. Company Details
    
    10.7.2.2. Business Overview
    
    10.7.2.3. Product Portfolio
    
    10.7.2.4. Financial Insights
    
    10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.2.6. SWOT Analysis
    
    10.7.2.7. Geographic Footprint
    
    10.7.3. Hoffmann-La Roche Ltd
    
    10.7.3.1. Company Details
    
    10.7.3.2. Business Overview
    
    10.7.3.3. Product Portfolio
    
    10.7.3.4. Financial Insights
    
    10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.3.6. SWOT Analysis
    
    10.7.3.7. Geographic Footprint
    
    10.7.4. Regeneron Pharmaceuticals Inc.
    
    10.7.4.1. Company Details
    
    10.7.4.2. Business Overview
    
    10.7.4.3. Product Portfolio
    
    10.7.4.4. Financial Insights
    
    10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.4.6. SWOT Analysis
    
    10.7.4.7. Geographic Footprint
    
    10.7.5. Carl Zeiss
    
    10.7.5.1. Company Details
    
    10.7.5.2. Business Overview
    
    10.7.5.3. Product Portfolio
    
    10.7.5.4. Financial Insights
    
    10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.5.6. SWOT Analysis
    
    10.7.5.7. Geographic Footprint
    
    10.7.6. Optos
    
    10.7.6.1. Company Details
    
    10.7.6.2. Business Overview
    
    10.7.6.3. Product Portfolio
    
    10.7.6.4. Financial Insights
    
    10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.6.6. SWOT Analysis
    
    10.7.6.7. Geographic Footprint
    
    10.7.7. Genentech, Inc.
    
    10.7.7.1. Company Details
    
    10.7.7.2. Business Overview
    
    10.7.7.3. Product Portfolio
    
    10.7.7.4. Financial Insights
    
    10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.7.6. SWOT Analysis
    
    10.7.7.7. Geographic Footprint
    
    10.7.8. AbbVie
    
    10.7.8.1. Company Details
    
    10.7.8.2. Business Overview
    
    10.7.8.3. Product Portfolio
    
    10.7.8.4. Financial Insights
    
    10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.8.6. SWOT Analysis
    
    10.7.8.7. Geographic Footprint
    
    10.7.9. Eli Lilly and Company
    
    10.7.9.1. Company Details
    
    10.7.9.2. Business Overview
    
    10.7.9.3. Product Portfolio
    
    10.7.9.4. Financial Insights
    
    10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.9.6. SWOT Analysis
    
    10.7.9.7. Geographic Footprint
    
    10.7.10. Viatris
    
    10.7.10.1. Company Details
    
    10.7.10.2. Business Overview
    
    10.7.10.3. Product Portfolio
    
    10.7.10.4. Financial Insights
    
    10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.10.6. SWOT Analysis
    
    10.7.10.7. Geographic Footprint
    
    10.7.11. AstraZeneca
    
    10.7.11.1. Company Details
    
    10.7.11.2. Business Overview
    
    10.7.11.3. Product Portfolio
    
    10.7.11.4. Financial Insights
    
    10.7.11.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.11.6. SWOT Analysis
    
    10.7.11.7. Geographic Footprint
    
    10.7.12. Bausch Health Companies Inc.
    
    10.7.12.1. Company Details
    
    10.7.12.2. Business Overview
    
    10.7.12.3. Product Portfolio
    
    10.7.12.4. Financial Insights
    
    10.7.12.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.12.6. SWOT Analysis
    
    10.7.12.7. Geographic Footprint
- 11. Methodology and Data Source
  - 11.1. Methodology/Research Approach
  - 11.2. Market Size Estimation
  - 11.3. Market Breakdown and Data Triangulation
  - 11.4. Data Source
  - 11.5. Secondary Sources
  - 11.6. Primary Sources
  - 11.7. Appendix
  - 11.8. Disclaimer
- List of Tables
  - Table 1. Global Diabetic Retinopathy Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 2. Global Diabetic Retinopathy Market Value (US$ Mn), By Application, 2020-2034
  - Table 3. Global Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 4. Global Diabetic Retinopathy Market Value (US$ Mn), By Region, 2020-2034
  - Table 5. North America Diabetic Retinopathy Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 6. North America Diabetic Retinopathy Market Value (US$ Mn), By Application, 2020-2034
  - Table 7. North America Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 8. North America Diabetic Retinopathy Market Value (US$ Mn), By Country, 2020-2034
  - Table 9. The US Diabetic Retinopathy Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 10. The US Diabetic Retinopathy Market Value (US$ Mn), By Application, 2020-2034
  - Table 11. The US Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 12. Canada Diabetic Retinopathy Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 13. Canada Diabetic Retinopathy Market Value (US$ Mn), By Application, 2020-2034
  - Table 14. Canada Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 15. Europe Diabetic Retinopathy Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 16. Europe Diabetic Retinopathy Market Value (US$ Mn), By Application, 2020-2034
  - Table 17. Europe Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 18. Europe Diabetic Retinopathy Market Value (US$ Mn), By Country, 2020-2034
  - Table 19. Germany Diabetic Retinopathy Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 20. Germany Diabetic Retinopathy Market Value (US$ Mn), By Application, 2020-2034
  - Table 21. Germany Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 22. The UK Diabetic Retinopathy Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 23. The UK Diabetic Retinopathy Market Value (US$ Mn), By Application, 2020-2034
  - Table 24. The UK Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 25. France Diabetic Retinopathy Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 26. France Diabetic Retinopathy Market Value (US$ Mn), By Application, 2020-2034
  - Table 27. France Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 28. Spain Diabetic Retinopathy Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 29. Spain Diabetic Retinopathy Market Value (US$ Mn), By Application, 2020-2034
  - Table 30. Spain Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 31. Italy Diabetic Retinopathy Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 32. Italy Diabetic Retinopathy Market Value (US$ Mn), By Application, 2020-2034
  - Table 33. Italy Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 34. Russia Diabetic Retinopathy Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 35. Russia Diabetic Retinopathy Market Value (US$ Mn), By Application, 2020-2034
  - Table 36. Russia Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 37. Netherland Diabetic Retinopathy Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 38. Netherland Diabetic Retinopathy Market Value (US$ Mn), By Application, 2020-2034
  - Table 39. Netherland Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 40. Rest of Europe Diabetic Retinopathy Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 41. Rest of Europe Diabetic Retinopathy Market Value (US$ Mn), By Application, 2020-2034
  - Table 42. Rest of Europe Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 43. Asia Pacific Diabetic Retinopathy Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 44. Asia Pacific Diabetic Retinopathy Market Value (US$ Mn), By Application, 2020-2034
  - Table 45. Asia Pacific Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 46. Asia Pacific Diabetic Retinopathy Market Value (US$ Mn), By Country, 2020-2034
  - Table 47. China Diabetic Retinopathy Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 48. China Diabetic Retinopathy Market Value (US$ Mn), By Application, 2020-2034
  - Table 49. China Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 50. India Diabetic Retinopathy Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 51. India Diabetic Retinopathy Market Value (US$ Mn), By Application, 2020-2034
  - Table 52. India Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 53. Japan Diabetic Retinopathy Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 54. Japan Diabetic Retinopathy Market Value (US$ Mn), By Application, 2020-2034
  - Table 55. Japan Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 56. South Korea Diabetic Retinopathy Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 57. South Korea Diabetic Retinopathy Market Value (US$ Mn), By Application, 2020-2034
  - Table 58. South Korea Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 59. Australia Diabetic Retinopathy Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 60. Australia Diabetic Retinopathy Market Value (US$ Mn), By Application, 2020-2034
  - Table 61. Australia Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 62. New Zealand Diabetic Retinopathy Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 63. New Zealand Diabetic Retinopathy Market Value (US$ Mn), By Application, 2020-2034
  - Table 64. New Zealand Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 65. Singapore Diabetic Retinopathy Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 66. Singapore Diabetic Retinopathy Market Value (US$ Mn), By Application, 2020-2034
  - Table 67. Singapore Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 68. Thailand Diabetic Retinopathy Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 69. Thailand Diabetic Retinopathy Market Value (US$ Mn), By Application, 2020-2034
  - Table 70. Thailand Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 71. Vietnam Diabetic Retinopathy Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 72. Vietnam Diabetic Retinopathy Market Value (US$ Mn), By Application, 2020-2034
  - Table 73. Vietnam Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 74. Rest of Asia Pacific Diabetic Retinopathy Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 75. Rest of Asia Pacific Diabetic Retinopathy Market Value (US$ Mn), By Application, 2020-2034
  - Table 76. Rest of Asia Pacific Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 77. Latin America Diabetic Retinopathy Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 78. Latin America Diabetic Retinopathy Market Value (US$ Mn), By Application, 2020-2034
  - Table 79. Latin America Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 80. Latin America Diabetic Retinopathy Market Value (US$ Mn), By Country, 2020-2034
  - Table 81. Brazil Diabetic Retinopathy Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 82. Brazil Diabetic Retinopathy Market Value (US$ Mn), By Application, 2020-2034
  - Table 83. Brazil Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 84. Mexico Diabetic Retinopathy Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 85. Mexico Diabetic Retinopathy Market Value (US$ Mn), By Application, 2020-2034
  - Table 86. Mexico Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 87. Rest of Latin America Diabetic Retinopathy Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 88. Rest of Latin America Diabetic Retinopathy Market Value (US$ Mn), By Application, 2020-2034
  - Table 89. Rest of Latin America Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 90. Middle East & Africa Diabetic Retinopathy Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 91. Middle East & Africa Diabetic Retinopathy Market Value (US$ Mn), By Application, 2020-2034
  - Table 92. Middle East & Africa Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 93. Middle East & Africa Diabetic Retinopathy Market Value (US$ Mn), By Country, 2020-2034
  - Table 94. South Africa Diabetic Retinopathy Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 95. South Africa Diabetic Retinopathy Market Value (US$ Mn), By Application, 2020-2034
  - Table 96. South Africa Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 97. Saudi Arabia Diabetic Retinopathy Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 98. Saudi Arabia Diabetic Retinopathy Market Value (US$ Mn), By Application, 2020-2034
  - Table 99. Saudi Arabia Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 100. UAE Diabetic Retinopathy Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 101. UAE Diabetic Retinopathy Market Value (US$ Mn), By Application, 2020-2034
  - Table 102. UAE Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 103. Rest of Middle East & Africa Diabetic Retinopathy Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 104. Rest of Middle East & Africa Diabetic Retinopathy Market Value (US$ Mn), By Application, 2020-2034
  - Table 105. Rest of Middle East & Africa Diabetic Retinopathy Market Value (US$ Mn), By Distribution Channel, 2020-2034
- List of Figures
  - Figure 1. Global Diabetic Retinopathy Market Snapshot: Market Value (US$ Mn), 2020-2034
  - Figure 2. Opportunity Map
  - Figure 3. Opportunity Orbit
  - Figure 4. Regional Market Share and BPS Analysis in Diabetic Retinopathy Market
  - Figure 5. Global Diabetic Retinopathy Market Analysis, By Product Type, 2020, 2024 and 2034
  - Figure 6. Global Diabetic Retinopathy Market Attractiveness Analysis, By Product Type
  - Figure 7. Global Diabetic Retinopathy Market Analysis, By Application, 2020, 2024 and 2034
  - Figure 8. Global Diabetic Retinopathy Market Attractiveness Analysis, By Application
  - Figure 9. Global Diabetic Retinopathy Market Analysis, By Distribution Channel, 2020, 2024 and 2034
  - Figure 10. Global Diabetic Retinopathy Market Attractiveness Analysis, By Distribution Channel
  - Figure 11. Global Diabetic Retinopathy Market Analysis, By Region, 2020, 2024 and 2034
  - Figure 12. Global Diabetic Retinopathy Market Attractiveness Analysis, By Region
  - Figure 13. North America Diabetic Retinopathy Market Analysis, By Product Type, 2020, 2024 and 2034
  - Figure 14. North America Diabetic Retinopathy Market Attractiveness Analysis, By Product Type
  - Figure 15. North America Diabetic Retinopathy Market (US$ Mn), by Non-Proliferative Diabetic Retinopathy (NPDR), 2020-2034
  - Figure 16. North America Diabetic Retinopathy Market (US$ Mn), by Proliferative Diabetic Retinopathy (PDR), 2020-2034
  - Figure 17. North America Diabetic Retinopathy Market Analysis, By Application, 2020, 2024 and 2034
  - Figure 18. North America Diabetic Retinopathy Market Attractiveness Analysis, By Application
  - Figure 19. North America Diabetic Retinopathy Market (US$ Mn), by Anti-VEGF Injections, 2020-2034
  - Figure 20. North America Diabetic Retinopathy Market (US$ Mn), by Corticosteroids, 2020-2034
  - Figure 21. North America Diabetic Retinopathy Market (US$ Mn), by Laser Treatment, 2020-2034
  - Figure 22. North America Diabetic Retinopathy Market (US$ Mn), by Surgery, 2020-2034
  - Figure 23. North America Diabetic Retinopathy Market Analysis, By Distribution Channel, 2020, 2024 and 2034
  - Figure 24. North America Diabetic Retinopathy Market Attractiveness Analysis, By Distribution Channel
  - Figure 25. North America Diabetic Retinopathy Market (US$ Mn), by Hospitals & Clinics, 2020-2034
  - Figure 26. North America Diabetic Retinopathy Market (US$ Mn), by Ophthalmology Centers, 2020-2034
  - Figure 27. North America Diabetic Retinopathy Market (US$ Mn), by Others, 2020-2034
  - Figure 28. North America Diabetic Retinopathy Market Analysis, By Country, 2020, 2024 and 2034
  - Figure 29. North America Diabetic Retinopathy Market Attractiveness Analysis, By Country
  - Figure 30. Europe Diabetic Retinopathy Market Analysis, By Product Type, 2020, 2024 and 2034
  - Figure 31. Europe Diabetic Retinopathy Market Attractiveness Analysis, By Product Type
  - Figure 32. Europe Diabetic Retinopathy Market (US$ Mn), by Non-Proliferative Diabetic Retinopathy (NPDR), 2020-2034
  - Figure 33. Europe Diabetic Retinopathy Market (US$ Mn), by Proliferative Diabetic Retinopathy (PDR), 2020-2034
  - Figure 34. Europe Diabetic Retinopathy Market Analysis, By Application, 2020, 2024 and 2034
  - Figure 35. Europe Diabetic Retinopathy Market Attractiveness Analysis, By Application
  - Figure 36. Europe Diabetic Retinopathy Market (US$ Mn), by Anti-VEGF Injections, 2020-2034
  - Figure 37. Europe Diabetic Retinopathy Market (US$ Mn), by Corticosteroids, 2020-2034
  - Figure 38. Europe Diabetic Retinopathy Market (US$ Mn), by Laser Treatment, 2020-2034
  - Figure 39. Europe Diabetic Retinopathy Market (US$ Mn), by Surgery, 2020-2034
  - Figure 40. Europe Diabetic Retinopathy Market Analysis, By Distribution Channel, 2020, 2024 and 2034
  - Figure 41. Europe Diabetic Retinopathy Market Attractiveness Analysis, By Distribution Channel
  - Figure 42. Europe Diabetic Retinopathy Market (US$ Mn), by Hospitals & Clinics, 2020-2034
  - Figure 43. Europe Diabetic Retinopathy Market (US$ Mn), by Ophthalmology Centers, 2020-2034
  - Figure 44. Europe Diabetic Retinopathy Market (US$ Mn), by Others, 2020-2034
  - Figure 45. Europe Diabetic Retinopathy Market Analysis, By Country, 2020, 2024 and 2034
  - Figure 46. Europe Diabetic Retinopathy Market Attractiveness Analysis, By Country
  - Figure 47. Asia Pacific Diabetic Retinopathy Market Analysis, By Product Type, 2020, 2024 and 2034
  - Figure 48. Asia Pacific Diabetic Retinopathy Market Attractiveness Analysis, By Product Type
  - Figure 49. Asia Pacific Diabetic Retinopathy Market (US$ Mn), by Non-Proliferative Diabetic Retinopathy (NPDR), 2020-2034
  - Figure 50. Asia Pacific Diabetic Retinopathy Market (US$ Mn), by Proliferative Diabetic Retinopathy (PDR), 2020-2034
  - Figure 51. Asia Pacific Diabetic Retinopathy Market Analysis, By Application, 2020, 2024 and 2034
  - Figure 52. Asia Pacific Diabetic Retinopathy Market Attractiveness Analysis, By Application
  - Figure 53. Asia Pacific Diabetic Retinopathy Market (US$ Mn), by Anti-VEGF Injections, 2020-2034
  - Figure 54. Asia Pacific Diabetic Retinopathy Market (US$ Mn), by Corticosteroids, 2020-2034
  - Figure 55. Asia Pacific Diabetic Retinopathy Market (US$ Mn), by Laser Treatment, 2020-2034
  - Figure 56. Asia Pacific Diabetic Retinopathy Market (US$ Mn), by Surgery, 2020-2034
  - Figure 57. Asia Pacific Diabetic Retinopathy Market Analysis, By Distribution Channel, 2020, 2024 and 2034
  - Figure 58. Asia Pacific Diabetic Retinopathy Market Attractiveness Analysis, By Distribution Channel
  - Figure 59. Asia Pacific Diabetic Retinopathy Market (US$ Mn), by Hospitals & Clinics, 2020-2034
  - Figure 60. Asia Pacific Diabetic Retinopathy Market (US$ Mn), by Ophthalmology Centers, 2020-2034
  - Figure 61. Asia Pacific Diabetic Retinopathy Market (US$ Mn), by Others, 2020-2034
  - Figure 62. Asia Pacific Diabetic Retinopathy Market Analysis, By Country, 2020, 2024 and 2034
  - Figure 63. Asia Pacific Diabetic Retinopathy Market Attractiveness Analysis, By Country
  - Figure 64. Latin America Diabetic Retinopathy Market Analysis, By Product Type, 2020, 2024 and 2034
  - Figure 65. Latin America Diabetic Retinopathy Market Attractiveness Analysis, By Product Type
  - Figure 66. Latin America Diabetic Retinopathy Market (US$ Mn), by Non-Proliferative Diabetic Retinopathy (NPDR), 2020-2034
  - Figure 67. Latin America Diabetic Retinopathy Market (US$ Mn), by Proliferative Diabetic Retinopathy (PDR), 2020-2034
  - Figure 68. Latin America Diabetic Retinopathy Market Analysis, By Application, 2020, 2024 and 2034
  - Figure 69. Latin America Diabetic Retinopathy Market Attractiveness Analysis, By Application
  - Figure 70. Latin America Diabetic Retinopathy Market (US$ Mn), by Anti-VEGF Injections, 2020-2034
  - Figure 71. Latin America Diabetic Retinopathy Market (US$ Mn), by Corticosteroids, 2020-2034
  - Figure 72. Latin America Diabetic Retinopathy Market (US$ Mn), by Laser Treatment, 2020-2034
  - Figure 73. Latin America Diabetic Retinopathy Market (US$ Mn), by Surgery, 2020-2034
  - Figure 74. Latin America Diabetic Retinopathy Market Analysis, By Distribution Channel, 2020, 2024 and 2034
  - Figure 75. Latin America Diabetic Retinopathy Market Attractiveness Analysis, By Distribution Channel
  - Figure 76. Latin America Diabetic Retinopathy Market (US$ Mn), by Hospitals & Clinics, 2020-2034
  - Figure 77. Latin America Diabetic Retinopathy Market (US$ Mn), by Ophthalmology Centers, 2020-2034
  - Figure 78. Latin America Diabetic Retinopathy Market (US$ Mn), by Others, 2020-2034
  - Figure 79. Latin America Diabetic Retinopathy Market Analysis, By Country, 2020, 2024 and 2034
  - Figure 80. Latin America Diabetic Retinopathy Market Attractiveness Analysis, By Country
  - Figure 81. Middle East & Africa Diabetic Retinopathy Market Analysis, By Product Type, 2020, 2024 and 2034
  - Figure 82. Middle East & Africa Diabetic Retinopathy Market Attractiveness Analysis, By Product Type
  - Figure 83. Middle East & Africa Diabetic Retinopathy Market (US$ Mn), by Non-Proliferative Diabetic Retinopathy (NPDR), 2020-2034
  - Figure 84. Middle East & Africa Diabetic Retinopathy Market (US$ Mn), by Proliferative Diabetic Retinopathy (PDR), 2020-2034
  - Figure 85. Middle East & Africa Diabetic Retinopathy Market Analysis, By Application, 2020, 2024 and 2034
  - Figure 86. Middle East & Africa Diabetic Retinopathy Market Attractiveness Analysis, By Application
  - Figure 87. Middle East & Africa Diabetic Retinopathy Market (US$ Mn), by Anti-VEGF Injections, 2020-2034
  - Figure 88. Middle East & Africa Diabetic Retinopathy Market (US$ Mn), by Corticosteroids, 2020-2034
  - Figure 89. Middle East & Africa Diabetic Retinopathy Market (US$ Mn), by Laser Treatment, 2020-2034
  - Figure 90. Middle East & Africa Diabetic Retinopathy Market (US$ Mn), by Surgery, 2020-2034
  - Figure 91. Middle East & Africa Diabetic Retinopathy Market Analysis, By Distribution Channel, 2020, 2024 and 2034
  - Figure 92. Middle East & Africa Diabetic Retinopathy Market Attractiveness Analysis, By Distribution Channel
  - Figure 93. Middle East & Africa Diabetic Retinopathy Market (US$ Mn), by Hospitals & Clinics, 2020-2034
  - Figure 94. Middle East & Africa Diabetic Retinopathy Market (US$ Mn), by Ophthalmology Centers, 2020-2034
  - Figure 95. Middle East & Africa Diabetic Retinopathy Market (US$ Mn), by Others, 2020-2034
  - Figure 96. Middle East & Africa Diabetic Retinopathy Market Analysis, By Country, 2020, 2024 and 2034
  - Figure 97. Middle East & Africa Diabetic Retinopathy Market Attractiveness Analysis, By Country
- Novartis AG Company Profile
- Bayer AG Company Profile
- Hoffmann-La Roche Ltd
- Regeneron Pharmaceuticals Inc.
- Carl Zeiss
- Optos
- Genentech Inc.
- AbbVie Inc. Company Profile
- Eli Lilly and Company
- Viatris
- AstraZeneca Plc Company Profile
- Bausch Health Companies Inc.
Settings

Related Reports

Our Clients

Inquiry Before Buying

Report ID 145648
Published Date April 2025
Rating
- ★★★★★
  
  ★★★★★
- (142)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)